Zealand Pharma A/S has appointed Rachel James-Owens as vice president, corporate communications & media relations. She brings over 20 years of experience from Pfizer and Novartis spanning sales, commercial and communications. Most recently, she was executive director, global corporate communications at Novartis Global Health & Sustainability and prior to that, she led global executive oncology communications at Novartis and held regional positions at Pfizer. Earlier this year Roche signed an agreement with the Danish company to co-develop a synthetic peptide analogue of amylin, a peptide hormone. The drug, petrelintide, is being developed for obesity.
Zealand Pharma announced the appointment on 25 September 2025.
Copyright 2025 Evernow Publishing Ltd.